Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2006
12/13/2006CN1289509C Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, and pharmaceutical compositions containing same
12/13/2006CN1289508C Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same
12/13/2006CN1289506C Gambogic aid compound complex, its preparing method and medicinal composition containing the complex as active ingredient
12/13/2006CN1289505C Novel compound gamboges new acid chemical structure, medicine preparation using said compound as active component, its application
12/13/2006CN1289502C New derivatives of benzo[a]pyrano[3,2-h]acridin-7-one, a process for their preparation and pharmaceutical compounds containing them
12/13/2006CN1289500C Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
12/13/2006CN1289499C Pirazino (aza) indole derivatives
12/13/2006CN1289498C 1-methylcarbapenem derivatives
12/13/2006CN1289497C 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1.1-dioxo-1 lambda b-thiomorpholin-4-yl)-4-(methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-N-methyl-isobutyramide
12/13/2006CN1289496C Process for producing novel paroxetine hydrochloride anhydrate
12/13/2006CN1289495C New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
12/13/2006CN1289490C Oxa-and thiazole derivatives useful as antidiabetic and antibesity agents
12/13/2006CN1289486C Pyrimidine derivatives as regulating agent of insulin-like growth factor-1 receptor (igf-1)
12/13/2006CN1289485C Preparation of an anhydrous quinoline-based EETP inhibitor by crystallization
12/13/2006CN1289483C Heterocyclic derivatives of glycinamide and its pharmaceutical uses
12/13/2006CN1289482C Organic acid salt of amlodipine
12/13/2006CN1289481C Biphenylcarboxamides useful as lipid lowering agents
12/13/2006CN1289479C 5-cyclo indole compounds as 5-HT receptor ligands
12/13/2006CN1289475C N-substituted aminotetralins as ligands for the neuropeptide YY5 receptor useful in the treatment of obesity and other disorders
12/13/2006CN1289471C 3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
12/13/2006CN1289469C Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors
12/13/2006CN1289466C Pharmaceutical compounds
12/13/2006CN1289455C 2-(2,6-dichlorophenyl)-diarylimidazoles
12/13/2006CN1289142C Medicinal new dosage form containing SA liposome as medicine carrier
12/13/2006CN1289130C Medicine for treating throat disease
12/13/2006CN1289120C Plaster for treating initial stage lymphoid tuberculosis
12/13/2006CN1289103C Immune function regulating antibiotic and anti-inflammatory drug with broad spectrum
12/13/2006CN1289102C Chinese-western medicine compound suppository for treating prostatic diseases
12/13/2006CN1289097C Medicament for treating drying crack or limb, contact dermatitis
12/13/2006CN1289094C 三磷酸腺苷盐组合物 Adenosine triphosphate salt composition
12/13/2006CN1289093C Breviscapine drop pills and its preparing method
12/13/2006CN1289092C Intestine micro ecological regulating agent
12/13/2006CN1289091C Pharmaceutical composition for treatment of inflammatory conditions and related use
12/13/2006CN1289090C Highly selective norepinephrine reuptake inhibitors and use thereof in medicament preparation
12/13/2006CN1289089C Application of camptothecin derivative in drug preparing process for treating marrow originate leukemia
12/13/2006CN1289088C Method for improving liposome enveloping rate of camptothecine or its derivatives
12/13/2006CN1289087C Quinoline derivatives as neuropeptide y antagonists
12/13/2006CN1289086C Uses for anti-malarial therapeutic agents
12/13/2006CN1289085C Nasal spray agent
12/13/2006CN1289084C Pharmaceutical formulation
12/13/2006CN1289083C 2-methylthiazolidine-2,4-dicarboxylic acid and the salts thereof used for the treatment of neurodegenerative diseases
12/13/2006CN1289082C Medicine composition for treating diabetes
12/13/2006CN1289081C Pharmaceutical composition for modified release insulin sensitiser
12/13/2006CN1289080C Vegetable estrogen analogy composition capable of replacing estrogen and its application
12/13/2006CN1289079C Use of an cactus extract and compounds isolated therefrom for protecting nerve cells
12/13/2006CN1289078C Novel paclitaxel emulsion for intravenous injection and its preparation method
12/13/2006CN1289077C Trimebutine maleate tablet and preparing method thereof
12/13/2006CN1289076C Soluble stable pharmaceutical composition containing ritonavir and a process for the preparation of concentrated pharmaceutical compositions
12/13/2006CN1289075C Use of trans-clomiphene-enriched clomiphene composition
12/13/2006CN1289074C Method for preparing sodium ferulate sterilized raw-material medicine
12/13/2006CN1289073C Hair growth stimulant
12/13/2006CN1289072C Aniline derivatives or salts thereof and cytokine prodn inhibitors containing same
12/13/2006CN1289071C Use of tramadol in preparation of medicine in delaying ejaculation
12/13/2006CN1289070C Anti-oxidation storage solution for organism simple
12/13/2006CN1289069C Pharmaceutical composition comprising a 5HT1 receptor agonist
12/13/2006CN1289064C Drug delivery system
12/12/2006US7148380 Bio-energy muscle relaxants
12/12/2006US7148378 Analgesics; neuropathic pain; bipolar disorders
12/12/2006US7148376 Crystal structures of (-)-N-(trans-4-isopropylcyclohexanecarbonyl)-D-Phenylalanine and solvates used as hypoglycemic agents
12/12/2006US7148372 1,1-bis(alkoxycarbonyl)-omega-tert-amino branched chain alkenes or conjugated polyenes; especially for the synthesis of retinoic acid, vitamin A (retinol), retinal, retinonitrile and etretinate
12/12/2006US7148359 Protease inhibitors; viricides; purity, crystal structure
12/12/2006US7148358 Process for the preparation of S(−) amlodipine-L(+)-hemi taratarte
12/12/2006US7148353 For therapy of anxiety and insomnia
12/12/2006US7148352 Method of inhibiting neurotrophin-receptor binding
12/12/2006US7148350 Compounds in the form of homodimeric or heterodimeric pro-drugs; process for obtaining these pro-drugs and their acceptable pharmaceutical salts and use of compounds in the treatment of phosphodiesterases-mediated diseases or dysfunction
12/12/2006US7148348 Process for preparing pyrrolotriazine aniline compounds useful as kinase inhibitors
12/12/2006US7148337 drug target and diagnostic marker for prostate cancer; host cells and expression vectors
12/12/2006US7148329 For modulating, in particular increasing or reducing, the immune response in an animal, such as a human or another mammal
12/12/2006US7148259 hydroxyamidines; antibiotic resistance
12/12/2006US7148258 Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity
12/12/2006US7148257 Methods of treating mesothelioma with suberoylanilide hydroxamic acid
12/12/2006US7148256 Made by reacting a dimer acid with an alkanolamine; hair and skin conditioners; nontoxic and nonirritating; dimethylaminopropyl amine free
12/12/2006US7148255 Amidoacetonitrile compounds
12/12/2006US7148254 2-Phenylbenzofuran derivatives, a process for preparing them, and their use
12/12/2006US7148253 4-thio coumarins
12/12/2006US7148252 Therapy or prphylaxis of primary brain cancer or a brain metastasis in a patient, comprising administering benzopyranones derivatives or their pharmaceutically acceptable salts
12/12/2006US7148251 D-t-3',4'-ethylenedioxy-p4 derivatives; glucosyl ceramide inhibitors lower glycosphingolipid levels; anticarcinogenic, antitumor agents; angiogenesis inhibitors; tumor antigens
12/12/2006US7148250 Indoles as NAALADase inhibitors
12/12/2006US7148249 Indolinones substituted by heterocycles, the preparation thereof and their use as medicaments
12/12/2006US7148248 Method of treating or inhibiting the development of brain inflammation and sepsis
12/12/2006US7148247 Substituted benzoxazoles as estrogenic agents
12/12/2006US7148246 Therapy, prevention diseases of fatty acid metabolism, glucose utilization; insulin resistance; antidiabetic agents; antilipemic agents
12/12/2006US7148245 Skin disorders; aging resistance of skins; antiinflammatory agents; antiallergens; rheumatic diseases; cardiovascular disorders
12/12/2006US7148244 Medicines in controlling Vpr function
12/12/2006US7148243 N-((2-hydroxy,3-(alkyloxo),6-halophenyl)-(1,2-cyclopropylene) -),N'-((5-cyano or bromo)pyrid-2-yl)urea; retroviricides; HIV reverse transcriptase inhibitors; prolonged time to virus resistance
12/12/2006US7148242 N-formyl hydroxylamine compounds, compositions and methods of use
12/12/2006US7148240 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same
12/12/2006US7148239 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof
12/12/2006US7148238 E.g., 4-[2-(4-Methylphenoxy)- or 4-[2-(4-Methylphenylsulfanyl)-phenyl]piperidine or the hydrochloride or oxalate; treating depression, anxiety disorder, and obsessive compulsive disorder.
12/12/2006US7148237 Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
12/12/2006US7148236 Modulate neurotransmission by promoting the release of neurotransmitters such as acetylcholine, dopamine and norepinephrine; thio-bridged aryl derivatives; treats central and autonomic nervous system disorders
12/12/2006US7148235 Heterocyclic amines such as 3-[2-(4-(1H-indol-3-yl)-3,6-dihydro-1(2H)-pyridinyl)ethyl]-6-7-dimethoxy-4(3H)-quinazolinone, used as antidepressants or anxiolytic agents for prophylaxis of psychological disorders
12/12/2006US7148234 Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
12/12/2006US7148233 Treatment of cardiovascular and related pathologies
12/12/2006US7148232 Oxazolo, thiazolo and selenazolo [4,5-c]-quinolin-4-amines and analogs thereof
12/12/2006US7148231 [6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)amine hydrochloride polymorph
12/12/2006US7148230 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; 4-(3-chloro-2-fluoroanilino)-6-[1-(hydroxyacetyl)piperidin-4-yloxy]-7-methoxyquinazoline
12/12/2006US7148229 Antidiabetic agents
12/12/2006US7148228 Heat Shock Protein 90 (HSP90); inflammatory, autoimmune, neurological, cardiac fibrogenetic and proliferative disorders and infections, tumors, leukemias, neoplasms, cancers, carcinomas, stroke, ischemia, metabolic diseases, and malignant disease
12/12/2006US7148227 Fungicidal triazolopyrimidines, methods for producing the same, use thereof for combating harmful fungi and agents containing said substances